San Mateo, CA, United States of America

Kevin Nishimoto

This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Asterias Biotherapeutics, Inc., Geron Corporation. Active years: 2012-2019.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kevin Nishimoto: Innovator in Stem Cell Research

Introduction

Kevin Nishimoto is a prominent inventor based in San Mateo, California. He has made significant contributions to the field of stem cell research, particularly in the differentiation of primate pluripotent stem cells. With a total of two patents to his name, Nishimoto's work has the potential to impact medical science and therapeutic applications.

Latest Patents

Nishimoto's latest patents focus on the differentiation of primate pluripotent stem cells into hematopoietic lineage cells. The inventions provide methods for this differentiation, as well as hematopoietic lineage cells that are derived from primate pluripotent stem cells. Additionally, the patents include methods of using these cells and kits that comprise them, showcasing the practical applications of his research.

Career Highlights

Throughout his career, Kevin Nishimoto has worked with notable companies in the biotechnology sector, including Geron Corporation and Asterias Biotherapeutics, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Nishimoto's coworkers include Suyi Tseng and Anish Sen Majumdar. Their collaborative efforts have further advanced the research and development of stem cell technologies.

Conclusion

Kevin Nishimoto's innovative work in stem cell differentiation highlights his role as a key inventor in the biotechnology field. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…